Evidence map›Paper›PMID 24035365›Full record

ArticleImmunity2013

Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.

Michela Locci, Colin Havenar-Daughton, Elise Landais, Jennifer Wu, Mark A Kroenke, Cecilia L Arlehamn, Laura F Su, Rafael Cubas, Mark M Davis, Alessandro Sette and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 562 papers.

0numbers the graph read from it
0cells of the map it votes in
562citing papers in PubMed
28.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

562 citing papers in PubMed, 883 citations in OpenAlex.

  1. Trial
  2. Sustained immunotolerance in multiple sclerosis after stem cell transplant.Annals of clinical and translational neurology · 2022
    Trial
  3. Trial
  4. Protein/AS01Cell reports. Medicine · 2021
    Trial
  5. Article
  6. Targeting T follicular helper cells for lifelong health.Nature reviews. Drug discovery · 2026
    Review
  7. Article
  8. Review
  9. Protein-dependent CD4iScience · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. T Cell Responses During Dengue Infection.Current topics in microbiology and immunology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Multimodal analysis definesbioRxiv : the preprint server for biology · 2025
    Article

502 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Michela LocciDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA; Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92037, USA.
Colin Havenar-Daughton
Elise Landais
Jennifer Wu
Mark A Kroenke
Cecilia L Arlehamn
Laura F Su
Rafael Cubas
Mark M Davis
Alessandro Sette
Elias K Haddad
International AIDS Vaccine Initiative Protocol C Principal Investigators
Pascal Poignard
Shane Crotty
La Jolla Institute for Immunology · USHoward Hughes Medical Institute · USVaccine & Gene Therapy Institute of Florida · USInternational AIDS Vaccine Initiative · USScripps Research Institute · US

Funding

Support Component D/Vaccine Discovery, Concept to ClinicUM1AI100663 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI BAROUCH, DAN H. · 2012 to 2018
$131.5M
Viral correlates of neutralizing antibody responseU19AI090970 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI POIGNARD, PASCAL · 2010 to 2014
$9.3M
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
NIAID NIH HHS AI090970NIAID NIH HHS U19 AI090970NIAID NIH HHS UM1-AI10066NIAID NIH HHS UM1 AI100663
6 · The paper itself

Abstract

The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. It is now conceivable that an antibody-dependent HIV vaccine might be possible, given the discovery of HIV broadly neutralizing antibodies (bnAbs) in some HIV-infected individuals. However, these antibodies are difficult to develop and have characteristics indicative of a high degree of affinity maturation in germinal centers (GCs). CD4⁺ T follicular helper (Tfh) cells are specialized for B cell help and necessary for GCs. Therefore, the development of HIV bnAbs might depend on Tfh cells. Here, we identified in normal individuals a subpopulation of circulating memory PD-1⁺CXCR5⁺CD4⁺ T cells that are resting memory cells most related to bona fide GC Tfh cells by gene expression profile, cytokine profile, and functional properties. Importantly, the frequency of these cells correlated with the development of bnAbs against HIV in a large cohort of HIV⁺ individuals.

Indexed as

Amino Acid SequenceAntibodies, NeutralizingB-LymphocytesGene ExpressionGene Expression ProfilingGerminal CenterHIV-1HIV AntibodiesHIV InfectionsHumansImmunity, HumoralImmunologic MemoryMolecular Sequence DataProgrammed Cell Death 1 ReceptorReceptors, CXCR3Receptors, CXCR5Antibodies, NeutralizingCXCR3 protein, humanCXCR5 protein, humanHIV AntibodiesPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, CXCR3Receptors, CXCR5

Identifiers

PMID24035365
PMCPMC3996844
OpenAlexW1981732254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.